The prognosis of patients with early relapsed or refractory large B-cell lymphoma after the receipt of first-line chemoimmunotherapy is poor. In this international, phase 3 trial, we randomly assigned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results